|
"liao yw"的相關文件
顯示項目 1-10 / 21 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2021 |
Magnolol inhibits cancer stemness and IL-6/ Stat3 signaling in oral carcinomas
|
Peng, CY; Yu, CC; Huang, CC; Liao, YW; Hsieh, PL; Chu, PM; Yu, CH; Lin, SS |
| 中山醫學大學 |
2021 |
Er:YAG laser promotes proliferation and wound healing capacity of human periodontal ligament fibroblasts through Galectin-7 induction
|
Lin, TC; Yu, CC; Liu, CM; Hsieh, PL; Liao, YW; Yu, CH; Chen, CJ |
| 中山醫學大學 |
2021 |
Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis
|
Yu, CC; Liao, YW; Hsieh, PL; Chang, YC |
| 中山醫學大學 |
2021 |
Inhibition of lncRNA HOTTIP ameliorated myofibroblast activities and inflammatory cytokines in oral submucous fibrosis
|
Lee, YH; Yu, CC; Hsieh, PL; Liao, YW; Yu, CH; Su, TR |
| 中山醫學大學 |
2021 |
Honokiol inhibits arecoline-induced oral fibrogenesis through transforming growth factor-I3/Smad2/3 signaling inhibition
|
Chen, PY; Ho, DCY; Liao, YW; Hsieh, PL; Lu, KH; Tsai, LL; Su, SH; Yu, CC |
| 中山醫學大學 |
2021 |
Arecoline enhances miR-21 to promote buccal mucosal fibroblasts activation
|
Yang, HW; Yu, CC; Hsieh, PL; Liao, YW; Chu, PM; Yu, CH; Fang, CY |
| 中山醫學大學 |
2021 |
LncRNA MEG3 inhibits self-renewal and invasion abilities of oral cancer stem cells by sponging miR-421
|
Chen, PY; Hsieh, PL; Peng, CY; Liao, YW; Yu, CH; Yu, CC |
| 中山醫學大學 |
2021 |
Silencing periostin inhibits myofibroblast transdifferentiation of fibrotic buccal mucosal fibroblasts
|
Su, JY; Yu, CC; Peng, CY; Liao, YW; Hsieh, PL; Yang, LC; Yu, CH; Chou, MY |
| 中山醫學大學 |
2021 |
Magnolol ameliorates the accumulation of reactive oxidative stress and inflammation in diabetic periodontitis
|
Liu, CM; Chen, SH; Liao, YW; Yu, CH; Yu, CC; Hsieh, PL |
| 中山醫學大學 |
2021 |
LINC00084/miR-204/ZEB1 Axis Mediates Myofibroblastic Differentiation Activity in Fibrotic Buccal Mucosa Fibroblasts: Therapeutic Target for Oral Submucous Fibrosis
|
Lee, YH; Liao, YW; Lu, MY; Hsieh, PL; Yu, CC |
顯示項目 1-10 / 21 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
